Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


2013 UCL Consultants Award


In recognising successful UCL consulting projects, the UCL Consultants Awards seeks to honour UCL researchers who have collaborated with industry on a consultative level.

Dr Vanessa Diaz

Previous winner (2012) Dr Vanessa Diaz was selected for her leading project that aims to produce a roadmap for the realisation of the ‘Digital VPH Patient. The Digital Patient is a method of integrating diverse computational models and individual data to produce a computational patient avatar. This would allow revolutionary health prediction and disease treatment when the ‘Digital Me’ of a citizen needs to avail itself of health services. The project is worth a total of 1.3m euros.

UCL Consultants Ltd (UCLC) was established by UCL to bring its academics together with national and international clients, providing access to UCL’s leading-edge expertise and world-class facilities.

UCL Consultants offers a one-stop office for academics wishing to carry out consultancy work, providing comprehensive contractual, tendering and administrative support, enabling UCL staff to ensure timely, high-quality delivery to meet clients’ requirements. It has extensive experience in working with wide variety of clients including multi-national, governmental organisations, space agencies, international companies and SME’s.

The 2013 UCL Consultants Award will recognise the latest successful consultancy agreements operating through UCL.